RAPT Therapeutics (RAPT) Assets (2020 - 2024)
Historic Assets for Therapeutics (RAPT) over the last 5 years, with Q3 2024 value amounting to $108.5 million.
- Therapeutics' Assets fell 4569.17% to $108.5 million in Q3 2024 from the same period last year, while for Sep 2024 it was $108.5 million, marking a year-over-year decrease of 4569.17%. This contributed to the annual value of $173.3 million for FY2023, which is 3488.99% down from last year.
- As of Q3 2024, Therapeutics' Assets stood at $108.5 million, which was down 4569.17% from $127.2 million recorded in Q2 2024.
- Therapeutics' Assets' 5-year high stood at $266.2 million during Q4 2022, with a 5-year trough of $105.9 million in Q1 2021.
- Over the past 5 years, Therapeutics' median Assets value was $187.5 million (recorded in 2022), while the average stood at $179.5 million.
- In the last 5 years, Therapeutics' Assets soared by 7705.9% in 2022 and then tumbled by 4569.17% in 2024.
- Over the past 5 years, Therapeutics' Assets (Quarter) stood at $119.0 million in 2020, then skyrocketed by 66.96% to $198.6 million in 2021, then surged by 34.02% to $266.2 million in 2022, then tumbled by 34.89% to $173.3 million in 2023, then plummeted by 37.42% to $108.5 million in 2024.
- Its Assets was $108.5 million in Q3 2024, compared to $127.2 million in Q2 2024 and $155.8 million in Q1 2024.